Patent US4036227A successfully refreshed from Google Patents.
US4036227A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Osmotic releasing device having a plurality of release rate patterns
Assignee: Alza Corp
•
Filing: 1974-12-23
•
Granted: 1977-07-19
•
Expires: 1994-12-23
Abstract
Abstract An osmotic device for releasing a useful agent at different release rate patterns from the device in a selected environment is disclosed. The device is comprised of a wall surrounding and forming a compartment as a means for containing a useful agent and having a passageway for releasing the agent. The wall is comprised in at least a part of a material permeable to an external fluid and impermeable to the agent. A layer of a pattern rate controlling material that erodes in a selected environment for changing the release rate pattern of the device is carried on the semipermeable wall distant from the compartment. The agent is soluble in the fluid and exhibits an osmotic pressure gradient across the semipermeable wall against the fluid, or the agent has limited solubility and is admixed with an osmotically effective solute soluble in the fluid that exhibits an osmotic pressure gradient across the semipermeable wall against the fluid. In operation, agent is released from the device at different release rate patterns by the pattern rate controlling material eroding at a controlled rate to increase the amount of fluid available to the semipermeable wall for imbibition, which fluid is imbibed through the wall into the compartment producing a solution of the soluble agent or a solution of the osmotically effective solute containing the agent which is released through the passageway to the exterior of the device at a rate controlled by the permeability of the semipermeable wall and the osmotic pressure gradient across the wall of the device.
Inventors
- 👤 Alejandro Zaffaroni
- 👤 Alan S. Michaels
- 👤 Felix Theeuwes
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 11:17
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0004; A61F; A61F6/00; A61F6/06; A61F6/14; A61F6/142; A61F6/144; A61F9/00; A61F9/0008; A61F9/0017
Claims Analysis
Total Claims: 25
Claim 1
Independent Claim
252 words
An oral osmotic device for the controlled dispensing of a unit dosage amount of drug to the gastrointestinal tract, said device comprising; a. a shaped semipermeable wall formed of an inert, nontoxic material that is permeable to the passage of an external gastrointestinal tract fluid, substantially impermeable to the passage of drug, and maintains its integrity during the drug dispensing period; b. the wall surrounding and forming a compartment containing a unit dosage amount of drug, said drug being soluble in the external fluid and exhibiting an osmotic pressure gradient across the wall against the fluid when the device is in the environment of use; c. a layer formed of a nontoxic erodible material on the exterior surface of the semipermeable wall; d. a passageway communicating with the compartment and the exterior of the device for dispensing drug from the device and adapted to pass a therapeutically effective amount of drug in the environment of use; and, e. wherein in operation when the osmotic device is in the environment of use, the layer erodes at a controlled rate to regulate the amount of fluid available to the wall for imbibition by the osmotic device, with fluid imbibed through the wall into the compartment in a tendency towards osmotic equilibrium at a rate controlled by the permeability of the wall and the osmotic pressure gradient across the wall producing a drug solution that is dispensed from the device through the passageway at a controlled and continuous rate over a prolonged period of time.
Claim 2
Dependent Claim
252 words
An oral osmotic device for the controlled dispensing of a unit dosage amount of drug to the gastrointestinal tract, said device comprising; a. a shaped semipermeable wall formed of an inert, nontoxic material that is permeable to the passage of an external gastrointestinal tract fluid, substantially impermeable to the passage of drug, and maintains its integrity during the drug dispensing period; b. the wall surrounding and forming a compartment containing a unit dosage amount of drug, said drug being soluble in the external fluid and exhibiting an osmotic pressure gradient across the wall against the fluid when the device is in the environment of use; c. a layer formed of a nontoxic erodible material on the exterior surface of the semipermeable wall; d. a passageway communicating with the compartment and the exterior of the device for dispensing drug from the device and adapted to pass a therapeutically effective amount of drug in the environment of use; and, e. wherein in operation when the osmotic device is in the environment of use, the layer erodes at a controlled rate to regulate the amount of fluid available to the wall for imbibition by the osmotic device, with fluid imbibed through the wall into the compartment in a tendency towards osmotic equilibrium at a rate controlled by the permeability of the wall and the osmotic pressure gradient across the wall producing a drug solution that is dispensed from the device through the passageway at a controlled and continuous rate over a prolonged period of time.
Claim 3
Dependent Claim
32 words
The oral device according to claim 1, wherein the layer is impermeable to external fluid and erodes to expose the wall of the device when the device is in the gastrointestinal tract.
Claim 4
Dependent Claim
40 words
The oral device according to claim 1, wherein the layer is permeable to external fluid and surface erodes to regulate the amount of fluid available to the wall of the device when the device is present in the gastrointestinal tract.
Claim 5
Dependent Claim
43 words
The oral device according to claim 1, wherein the drug in the compartment is mixed with an organic or inorganic solute that is soluble in the fluid and exhibits an osmotic pressure gradient across the wall of the device against the gastrointestinal fluid.
Claim 6
Dependent Claim
34 words
The oral device according to claim 1, wherein the layer is formed of a non-toxic material, is substantially impermeable to external fluid and bioerodes to expose the wall of the device in the intestine.
Claim 7
Dependent Claim
35 words
The oral device according to claim 1 wherein the layer is permeable to external fluid and erodes in the intestine to vary the amount of fluid available to the wall of the device for imbibition.
Claim 8
Dependent Claim
18 words
The oral device according to claim 1, wherein the layer is formed of a bioerodible, non-toxic enteric material.
Claim 9
Dependent Claim
39 words
The oral device according to claim 1 wherein the layer is formed of a member selected from the group consisting of keratin, shellac, ammoniated shellac, shellac, n-butyl stearate, polyvinyl acid phthalate, methyl cellulose acid phthalate and cellulose acid phthalate.
Claim 10
Dependent Claim
25 words
The oral device according to claim 1, wherein the layer is formed a member selected from the group consisting of poly(carboxylic acid) and poly(acrylic acid).
Claim 11
Dependent Claim
35 words
The oral device according to claim 1 wherein the compartment additionally contains a member selected from the group consisting of a colloid, a dispersant, a binder, a gelling agent, a surfactant, and an emulsifying agent.
Claim 12
Dependent Claim
47 words
The oral device according to claim 1, wherein the drug is a member selected from the group consisting of acetazolamide, potassium chloride, quinine hydrochloride, sodium salicylate, diphenyl hydantoin, codiene, scopolamine, benzodiazepine, chlordiazepoxide, ephedrine, ascorbic acid, procainamide, nitroglycerine, 5-fluorouracil, insulin, tolbutamide, chlorpropamide, ferrous salts, chlorpromazine and acetylsalicylic acid.
Claim 13
Dependent Claim
50 words
The oral device according to claim 1, wherein the drug in the compartment is a member selected from the group consisting of physiologically and pharmacologically acting drugs with the drug present in a form selected from the group consisting of dispersion, tablet, solution, paste, cream, granule, emulsion, suspension and powder.
Claim 14
Dependent Claim
29 words
The oral device according to claim 1, wherein the semipermeable wall is formed a member selected from the group consisting of cellulose acetate, methyl cellulose, polyvinyl alcohol and polyurethane
Claim 15
Dependent Claim
143 words
The oral device according to claim 1 wherein the passageway has a maximum cross-sectional area A s , defined by (L/F) × (Q p /t) × (1/DS), wherein L is the length of the passageway, Q p /t is the mass of agent dispensed from the device per unit time, D is the diffusion coefficient of agent in the dispensed solution, S is the solubility of agent in fluid and F has a value of 2 to 1000, said passageway having a minimum area, A s defined by ##EQU27## wherein L is the length of the passageway, v/t is the volume of agent solution dispensed per unit time, π is 3.14, η is the viscosity of the solution being dispensed and ΔP is the hydrostatic pressure difference between the inside and the outside of the compartment having a value up to 20 atmospheres.
Claim 16
Dependent Claim
57 words
The oral device for the controlled dispensing of drug according to claim 1, wherein the solubility of the drug is limited in the fluid and the drug is mixed with an osmotically effective compound which compound is soluble in the fluid and also exhibits an osmotic pressure gradient across the wall of the device against the fluid.
Claim 17
Dependent Claim
30 words
The oral device for the controlled dispensing of drug according to claim 1, wherein the layer has a uniform thickness on the exterior surface of the wall of the device.
Claim 18
Dependent Claim
30 words
The oral device for the controlled dispensing of drug according to claim 1, wherein the layer has a varying thickness on the exterior surface of the wall of the device.
Claim 19
Dependent Claim
45 words
The oral device for the controlled dispensing of drug according to claim 1, wherein as the layer erodes at a controlled rate to a non-toxic product, the osmotic device incrementally changes the amount of drug dispensed through the passageway over a prolonged period of time.
Claim 20
Dependent Claim
83 words
The oral device for the controlled dispensing of drug according to claim 1, wherein the drug is a member selected from the group consisting of locally and systemically acting drugs, and wherein as the layer erodes in response to the environment of the gastrointestinal tract it exposes an increasing surface area of the wall of the device to fluid for imbibition by the device into the compartment, thereby increasing the amount of drug released by the device over a prolonged period of time.
Claim 21
Dependent Claim
38 words
The oral device for the controlled dispensing of drug according to claim 1, wherein the layer erodes to form a decreasing thinner layer thereby regulating and increasing the amount of external fluid available for imbibition by the device.
Claim 22
Dependent Claim
33 words
The oral device for the controlled dispensing of drug according to claim 1, wherein the layer is formed of a member selected from the group consisting of hydrophobic and hydrophilic erodible nontoxic materials.
Claim 23
Dependent Claim
83 words
The oral device for the controlled dispensing of drug according to claim 1, wherein (a) the layer is member selected from the group consisting of balsam of peru, balsam of tolu, styrene and combinations of dibutyl phthalate and talc, (b) the compartment contains a drug having limited solubility in the external fluid with the drug being dispensed as the layer erodes over a prolonged period of time, and (c) the semipermeable wall has a fluid permeability of 0.01 to 10 cc/cm 2 /hu.
Claim 24
Dependent Claim
43 words
The oral device for the controlled dispensing of drug according to claim 1 wherein the drug is a member selected from the group consisting of hypnotic, sedative, psychic energizer tranquilizer, anticonvulsant, analgesic, antipyretic, anti-inflammatory, antimicrobial, progestational, estrogenic, synpathomimetic, cardiovascular, antiparasitic, and diuretic drugs.
Claim 25
Dependent Claim
50 words
The oral device for the controlled dispensing of drug according to claim 1, wherein the gastrointestinal tract comprises a stomach and an intestine and the layer is formed of a material substantially resistant to the environment of the stomach and erodes in the environment of the intestine to non-toxic products.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-07-18 | 1981-01-17 | 1981-07-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-07-18 | 1985-01-17 | 1985-07-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-07-18 | 1989-01-17 | 1989-07-19 | $7700.00 | Window Closed / Lapsed |